The Office of Blood Research and Review, Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, needs to purchase a multi-mode spectrophotometer to be used to perform and develop highly sensitive ELISA based assays utilizing luminometer to detect anti-Zika antibodies in the serum of patients and to screen blood donors against Zika virus antibodies. The current instrument in our laboratory can only read UV-Visible wavelengths and is outdated, so we rely on the equipment of other labs to perform multiple critical experiments to further our research goals.

In accordance with FAR 6.302-1(c) this procurement is Brand Name only. FDA has identified the Spectramax M5 multimode microplate/cuvette reader as the only product that can meet this requirement.

Please see attached RFQ and Brand Name Justification

Bid Protests Not Available